Compositions for treating biofilms and methods for using same
Compositions containing a surface active agent and a sub-lethal amount of an antimicrobial agent and methods for using such compositions are provided herein.
1. A method for treating a chronic wound comprising applying a composition to the chronic wound comprising about 30 w/w % to about 80 w/w % surface active agent selected from the group consisting of poloxamer 127, poloxamer 188, poloxamer 237, poloxamer 335, poloxamer 407, and combinations thereof and about 1% or less by weight of the composition of an antimicrobial agent.
2. The method of claim 1 , wherein the antimicrobial agent is selected from the group consisting of an antibacterial, an antifungal, an antiviral or a combination thereof.
3. The method of claim 1 , wherein the antimicrobial agent is selected from the group consisting of furaltadone, furazolium chloride, nifuradene, nifuratel, nifurfoline, nifurpirinol, nifurprazine, nifurtoinol, nitrofurantoin, furazolidone, 2-(methoxymethyl)-5-nitrofuran, nidroxyzone, nifuroxime, nifurazide, nitrofurazone, nystatin, polymyxin, silver sulfadiazine, nanocrystalline silver, ionic silver, silver salts, iodine, benzalkonium chloride, alcohol, hydrogen peroxide, chlorhexidine, honey and combinations thereof.
4. The method of claim 1 , wherein the antimicrobial agent is silver sulfadiazine.
5. The method of claim 1 , wherein the surface active agent is poloxamer 188.
6. The method of claim 1 , wherein the chronic wound is selected from the group consisting of chronic venous ulcers, diabetic ulcers, arterial ulcers, pressure ulcers, decubitis ulcers, radiation ulcers, traumatic wounds, non-healing wounds, and combinations thereof.
7. A method for treating a chronic wound comprising contacting the chronic wound with a dressing having a composition comprising about 30 w/w % to about 80 w/w % surface active agent selected from the group consisting of poloxamer 127, poloxamer 188, poloxamer 237, poloxamer 335, poloxamer 407, and combinations thereof and about 1% or less by weight of the composition of an antimicrobial agent impregnated on a dressing material.
8. The method of claim 7 , wherein the antimicrobial agent is selected from the group consisting of an antibacterial, an antifungal, an antiviral, and combinations thereof.
9. The method of claim 7 , wherein the antimicrobial agent is selected from the group consisting of furaltadone, furazolium chloride, nifuradene, nifuratel, nifurfoline, nifurpirinol, nifurprazine, nifurtoinol, nitrofurantoin, furazolidone, 2-(methoxymethyl)-5-nitrofuran, nidroxyzone, nifuroxime, nifurazide, nitrofurazone, nystatin, polymyxin, silver sulfadiazine, nanocrystalline silver, ionic silver, silver salts, iodine, benzalkonium chloride, alcohol, hydrogen peroxide, chlorhexidine, honey, and combinations thereof.
10. The method of claim 7 , wherein the antimicrobial agent is silver sulfadiazine.
11. The method of claim 7 , wherein the surface active agent is poloxamer 188.
12. The method of claim 7 , wherein the chronic wound is selected from the group consisting of chronic venous ulcers, diabetic ulcers, arterial ulcers, pressure ulcers, decubitis ulcers, radiation ulcers, traumatic wounds, non-healing wounds, and combinations thereof.
13. The method of claim 7 , wherein contacting comprises applying the dressing to the chronic wound.
14. A method for treating a chronic wound comprising applying to the chronic wound a composition comprising about 30 w/w % to about 80 w/w % of poloxamer 188 and up to 1% by weight of the composition of silver sulfadiazine.
15. The method of claim 14 , wherein the chronic wound is selected from the group consisting of chronic venous ulcers, diabetic ulcers, arterial ulcers, pressure ulcers, decubitis ulcers, radiation ulcers, traumatic wounds, non-healing wounds, and combinations thereof.